Neuronetics is trading 6% up at $3.10, based on live price context; the catalyst remains unclear.
- No September 9, 2026 company-specific announcement, earnings release, scheduled investor event, or regulatory filing was identified.
- The investor-relations page lists no upcoming events, and its latest listed release is dated August 11, 2026.
- Healthcare is down 2.19%, while major indexes are also lower, so sector and market conditions do not clearly explain the opposite-direction move.